James Robertson
CIK 1388336 · View on SEC EDGAR ↗
Insider
First SEC filing: July 30, 2007 · Latest: Feb. 14, 2008
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 36 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2012 | IVZ | F | 13,539 | $24.96 | $337,933 | 878,901 Direct | -1.52% | Disposed | 29.0% (price as of 2026-08-21) |
| Feb. 28, 2012 | IVZ | A | 87,139 | — | — | 892,440 Direct | +10.82% | Acquired | (price as of 2026-08-21) |
| Feb. 27, 2012 | IVZ | F | 40,158 | $24.77 | $994,714 | 805,301 Direct | -4.75% | Disposed | 30.0% (price as of 2026-08-21) |
| Feb. 27, 2012 | IVZ | M | 78,740 | — | — | 845,459 Direct | +10.27% | Acquired | (price as of 2026-08-21) |
| Feb. 26, 2012 | IVZ | M | 78,740 | — | — | 78,740 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| Feb. 26, 2012 | IVZ | M | 35,198 | — | — | 70,397 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| Feb. 26, 2012 | IVZ | F | 17,951 | $24.88 | $446,621 | 766,719 Direct | -2.29% | Disposed | 29.4% (price as of 2026-08-21) |
| Feb. 26, 2012 | IVZ | M | 35,198 | — | — | 784,670 Direct | +4.70% | Acquired | (price as of 2026-08-21) |
| Feb. 28, 2011 | IVZ | F | 4,319 | $26.84 | $115,922 | 749,472 Direct | -0.57% | Disposed | 19.9% (price as of 2026-08-21) |
| Feb. 28, 2011 | IVZ | F | 18,512 | $26.84 | $496,862 | 753,791 Direct | -2.40% | Disposed | 19.9% (price as of 2026-08-21) |
| Feb. 28, 2011 | IVZ | A | 106,184 | — | — | 772,303 Direct | +15.94% | Acquired | (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | M | 78,740 | — | — | 157,480 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | M | 35,198 | — | — | 105,595 Direct | -25.00% | Disposed | (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | F | 17,599 | $26.40 | $464,614 | 666,119 Direct | -2.57% | Disposed | 21.9% (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | M | 35,198 | — | — | 683,718 Direct | +5.43% | Acquired | (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | F | 39,370 | $26.40 | $1,039,368 | 648,520 Direct | -5.72% | Disposed | 21.9% (price as of 2026-08-21) |
| Feb. 25, 2011 | IVZ | M | 78,740 | — | — | 687,890 Direct | +12.93% | Acquired | (price as of 2026-08-21) |
| Feb. 28, 2010 | IVZ | M | 78,740 | — | — | 236,220 Direct | -25.00% | Disposed | (price as of 2026-08-21) |
| Feb. 26, 2010 | IVZ | A | 140,793 | — | — | 140,793 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 26, 2010 | IVZ | F | 40,172 | $19.60 | $787,371 | 45,827 Direct | -46.71% | Disposed | 64.2% (price as of 2026-08-21) |
| Feb. 26, 2010 | IVZ | M | 78,740 | — | — | 85,999 Direct | +1084.72% | Acquired | (price as of 2026-08-21) |
| Feb. 27, 2009 | IVZ | A | 314,960 | — | — | 314,960 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 27, 2009 | IVZ | F | 2,804 | $11.43 | $32,050 | 577,645 Direct | -0.48% | Disposed | 181.6% (price as of 2026-08-21) |
| Feb. 27, 2009 | IVZ | F | 2,292 | $11.43 | $26,198 | 580,449 Direct | -0.39% | Disposed | 181.6% (price as of 2026-08-21) |
| Jan. 30, 2009 | IVZ | F | 13,151 | $11.79 | $155,050 | 570,582 Direct | -2.25% | Disposed | 173.0% (price as of 2026-08-21) |
| Jan. 30, 2009 | IVZ | F | 12,841 | $11.79 | $151,395 | 583,051 Direct | -2.15% | Disposed | 173.0% (price as of 2026-08-21) |
| Jan. 30, 2009 | IVZ | A | 33,794 | — | — | 595,892 Direct | +6.01% | Acquired | (price as of 2026-08-21) |
| Feb. 28, 2008 | IVZ | F | 2,998 | $27.01 | $80,976 | 560,972 Direct | -0.53% | Disposed | 19.2% (price as of 2026-08-21) |
| Feb. 28, 2008 | IVZ | A | 62,939 | — | — | 563,970 Direct | +12.56% | Acquired | (price as of 2026-08-21) |
| Jan. 9, 2008 | IVZ | F | 103,140 | $26.87 | $2,771,372 | 501,031 Direct | -17.07% | Disposed | 19.8% (price as of 2026-08-21) |
| Dec. 31, 2007 | IVZ | C | 250,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Dec. 31, 2007 | IVZ | C | 250,000 | — | — | 604,171 Direct | +70.59% | Acquired | (price as of 2026-08-21) |
| Dec. 28, 2007 | IVZ | D | 250,000 | $31.35 | $7,837,500 | 354,171 Direct | -41.38% | Disposed | 2.7% (price as of 2026-08-21) |
| Dec. 13, 2007 | IVZ | F | 3,887 | $27.36 | $106,348 | 600,284 Direct | -0.64% | Disposed | 17.7% (price as of 2026-08-21) |
| Nov. 30, 2007 | IVZ | C | 18,962 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 30, 2007 | IVZ | C | 9,481 | — | — | 604,171 Direct | +1.59% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 26, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares (78,740) | $0.00 | — | 78,740 | Disposed |
| Feb. 26, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares (35,198) | $0.00 | — | 35,198 | Disposed |
| Feb. 25, 2011 | IVZ | Restricted Stock Units [F1] | Common Shares (78,740) | $0.00 | — | 78,740 | Disposed |
| Feb. 25, 2011 | IVZ | Restricted Stock Units [F1] | Common Shares (35,198) | $0.00 | — | 35,198 | Disposed |
| Feb. 28, 2010 | IVZ | Deferred Share Award - Time Vesting [F3] | Common Shares (78,740) | $0.00 | — | 78,740 | Disposed |
| Feb. 26, 2010 | IVZ | Restricted Stock Units [F1] | Common Shares (140,793) | $0.00 | — | 140,793 | Acquired |
| Feb. 27, 2009 | IVZ | Restricted Stock Unit [F1] | Common Shares (314,960) | $0.00 | — | 314,960 | Acquired |
| Dec. 31, 2007 | IVZ | Deferred Share Awards - Time Vesting | Common Shares, par value $0.20 per share | $0.00 | — | 250,000 | Disposed |
| Nov. 30, 2007 | IVZ | Deferred Share Awards - Time Vesting | Common Shares, par value $0.20 per share | $0.00 | — | 18,962 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 30, 2007 | IVZ | Ordinary Shares , par value $0.10 per share | 1,147,002 | Direct |
| July 30, 2007 | IVZ | Ordinary Shares par value $0.10 per share [F1] | 42,379 | Direct |
| July 30, 2007 | IVZ | Deferred Share Awards-Time Vesting→ Ordinary Shares, par value $0.10 per share (500,000) | 500,000 | Direct |
| July 30, 2007 | IVZ | Deferred Share Awards-Time Vesting→ Ordinary Shares, par value $0.10 per share (18,962) | 18,962 | Direct |
| July 30, 2007 | IVZ | Options to Purchase-Time Vesting→ Ordinary Shares, par value $0.10 per share (150,000) | 150,000 | Direct |
| July 30, 2007 | IVZ | Options to Purchase-Time Vesting→ Ordinary Shares, par value $0.10 per share (150,000) | 150,000 | Direct |
| July 30, 2007 | IVZ | Options to Purchase-Time Vesting→ Ordinary Shares, par value $0.10 per share (100,000) | 100,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $557,398 | — | — | — | $1,006,908 | — | $769,128 | $5,183,417 |
| 2011 | $563,421 | — | — | — | $1,455,405 | — | $236,312 | $5,105,117 |
| 2010 | $540,280 | — | — | — | $1,400,000 | — | $579,663 | $5,279,486 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.